Biomass
$0.75
-29%
Broad Spectrum Distillate
$3,700.00
+6%
CBD Isolate
$1,125.00
-2%
CBG Isolate
$7,500.00
-6%
Water Soluble CBD Isolate
$2,100.00
+35%
Water Soluble CBD Broad Spectrum
$2,700.00
+13%
Back to news
21. July 2020
Food & Beverage News Production

CBN Infusion Technology Breakthrough Represents an Emerging Opportunity for Cannabis Global

Cannabis Global, Inc. (OTC PINK:MCTC) has announced that it has successfully developed novel production techniques  for the development of ground-breaking infused products derived from Cannabinol (CBN).

The company, which has previously developed infusion and delivery technologies for Tetrahydrocannabivarin (THC-V), has detailed its recent success in applying those techniques to another rare cannabinoid, Cannabinol (CBN) which Cannabis Global believes may have enormous unexplored upside growth potential as a new cannabinoid-based products market.

This breakthrough discovery results from continued work on the Company’s “Project Varin” initiative, a core R&D effort launched in January 2020 to manufacture new nanotechnologies, infusions and consumer products based on rare cannabinoids, which has thus far yielded several important product development and production methodology breakthroughs that the Company now believes will enable more effective commercialization of products based on rare cannabinoids.

Our research team has already proven our capability to produce high-quality polymeric nanoparticles and fibers of THC-V, but we also consider it important to be able to leverage our production techniques relative to other rare cannabinoids,” commented Arman Tabatabaei, CEO of Cannabis Global. “We are excited to report  the success of this effort, which comes in the form of the production of highly loaded nanofibers of CBN via our methods developed for THC-V. We believe this development allows Cannabis Global to more quickly expand our product portfolio as we continue to stake a claim in the rare cannabinoid sector, potentially unleashing underexploited growth potential in markets like CBN, with little or no real competition.”

The Company’s research team is nearing the completion of a subprogram of Project Varin designed to finalize high volume production methods. As part of this effort, manufactured CBN was successfully utilized, via the Company’s technologies, to produce highly loaded nanofibers. As an additional planned phase, the Company will seek to apply these established manufacturing protocols to other rare cannabinoids.

THC-V and CBN are not scheduled at the federal level. The Company’s THC-V products contain zero tetrahydrocannabinol (THC), far below the acceptable federal level of 0.3%, and zero heavy metals, pesticide and herbicide residues, nitrates and other impurities that are contained in most cannabis and hemp products.

Mr. Tabatabaei continued, “Project Varin has exceeded our most optimistic expectations. Our next phase of CBN research will involve the design of new and innovative products based on rare cannabinoid CBN. We plan to continue programs under Project Varin throughout the second half of this year, while simultaneously launching our nature-based hemp infused products under the Hemp You Can Feel™ brand name. These will include our coffee products, alcohol replacement cocktail mixers, Hemp & Booch kombucha line and several other unique offerings, all based on the finest ingredients available.

Source | Cannabis Global Inc